These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 286125)

  • 61. Study of the mechanism of Corynebacterium parvum anti-tumour activity. I. Protective effect on the growth of two syngeneic tumours.
    Mazurek C; Chalvet H; Stiffel CL; Biozzi G
    Int J Cancer; 1976 Apr; 17(4):511-7. PubMed ID: 946965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Experimental studies on active specific immunotherapy using the immune reaction of low-dose irradiated tumor tissues. Comparison of the effects of tumor cells and mononuclear cells].
    Imanaka K; Tanaka K; Sasai K; Nishizawa S; Sano A; Kuroda Y; Ashida C; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1438-42. PubMed ID: 6335162
    [No Abstract]   [Full Text] [Related]  

  • 63. Action of cancer chemotherapy-radiotherapy on spleen hypertrophy response to Corynebacterium parvum adjuvant therapy.
    Maruyama Y; Grider C; Feola J
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1691-8. PubMed ID: 536279
    [No Abstract]   [Full Text] [Related]  

  • 64. Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.
    Woodruff MF; Inchley MP; Dunbar N
    Br J Cancer; 1972 Apr; 26(2):67-76. PubMed ID: 5038327
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanism of Corynebacterium Parvum anti-tumour activity. II. Protective effect in T-cell-deprived mice.
    Mazurek C; Chalvet H; Stiffel C; Biozzi G
    Int J Cancer; 1977 Oct; 20(4):532-4. PubMed ID: 334678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radiation-induced osteogenic sarcoma of C3H mouse: effects of Corynebacterium parvum and WBI on its natural history and response to irradiation.
    Choi CH; Sedlacek RS; Suit HD
    Eur J Cancer (1965); 1979 Apr; 15(4):433-42. PubMed ID: 285860
    [No Abstract]   [Full Text] [Related]  

  • 67. Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.
    Likhite VV
    Int J Cancer; 1974 Nov; 14(5):684-90. PubMed ID: 4459281
    [No Abstract]   [Full Text] [Related]  

  • 68. [Comparison of the effect of irradiated tumor tissue with that of irradiated tumor cells in active specific immunotherapy].
    Ogawa Y; Maeda T; Yoshida S; Yamamoto Y; Morita M; Ogawa Y; Hiratsuka J; Imanaka K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1181-8. PubMed ID: 6663171
    [No Abstract]   [Full Text] [Related]  

  • 69. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 8. Effect of mitomycin C-treated active specific immunotherapy].
    Imanaka K; Gose K; Ichiyanagi A; Ashida C; Hamada F; Hashimura T; Takimoto S; Murakami M; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):940-5. PubMed ID: 6413626
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect of intracerebrally injected Corynebacterium parvum on the development and growth of metastatic brain tumor in mice.
    Kennedy JD; Sutton RC; Conley FK
    Neurosurgery; 1989 Nov; 25(5):709-14. PubMed ID: 2586725
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radiation response of C3H fibrosarcoma enhanced in mice stimulated by Corynebacterium parvum.
    Suit HD; Sedlacek R; Wagner M; Orsi L
    Nature; 1975 Jun; 255(5508):493-4. PubMed ID: 1138200
    [No Abstract]   [Full Text] [Related]  

  • 72. [Antigenic relationship between the chemically-induced mouse bladder tumor and Corynebacterium parvum].
    Fujioka T
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):560-5. PubMed ID: 6620769
    [No Abstract]   [Full Text] [Related]  

  • 73. Proceedings: Treatment of a metastasizing murine tumour with Corynebacterium parvum.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Feb; 31(2):264. PubMed ID: 1164486
    [No Abstract]   [Full Text] [Related]  

  • 74. C. parvum treatment of transplanted rat tumours of spontaneous origin.
    Willmott N; Pimm MV; Baldwin RW
    Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Glucagon suppressed proliferation rate of mammary aplastic carcinoma in mice.
    Pavelić K; Pavelić J
    Horm Metab Res; 1980; 12(6):243-6. PubMed ID: 7409736
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combination of cyclophosphamide and estrogen therapy in DMBA-induced rat mammary cancer.
    Kiang DT; Kennedy BJ
    Cancer; 1971 Nov; 28(5):1202-10. PubMed ID: 5125667
    [No Abstract]   [Full Text] [Related]  

  • 77. The delayed rejection of tumors formed from the administration of tumor cells mixed with killed Corynebacterium parvum.
    Likhite VV; Halpern BN
    Int J Cancer; 1973 Nov; 12(3):699-704. PubMed ID: 4524799
    [No Abstract]   [Full Text] [Related]  

  • 78. Protection against herpes simplex virus infection in mice by Corynebacterium parvum.
    Kirchner H; Hirt HM; Munk K
    Infect Immun; 1977 Apr; 16(1):9-11. PubMed ID: 194841
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Flow cytometric analysis of cell-kinetics after fractionated irradiation. II. A study on transplanted solid tumor after single dose irradiation].
    Sakai K; Fujita S; Hinata H; Sueyama H; Sato Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Feb; 45(2):398-402. PubMed ID: 4011415
    [No Abstract]   [Full Text] [Related]  

  • 80. Suppression of the incidence of death with spontaneous tumours in DBA/2 mice after Corynebacterium parvum-mediated rejection of syngeneic tumours.
    Likhite VV
    Nature; 1976 Feb; 259(5542):397-9. PubMed ID: 1250378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.